On March 24, it was announced that Johnson & Johnson’s Ethicon subsidiary had reached a settlement in a bellwether trial over their transvaginal mesh devices. That settlement came shortly after a California jury delivered a $5.7 million verdict against J&J’s Ethicon over their Gynecare TVT Abbrevo vaginal mesh device.
The settlement came during a bellwether trial that was part of a federal mass tort against J&J’s Ethicon division that included 30,000 cases. Including the Johnson and Johnson cases, there are currently over 70,000 cases in the United States relating to transvaginal mesh devices. Use of transvaginal mesh to repair pelvic organ prolapse became widespread in spite of early reports of problems caused by the mesh. In spite of manufacturer’s insistence on the safety of the devices, patients suffered horrific complications following implantation of pelvic mesh in hundreds of thousands of women during surgeries to treat pelvic organ prolapse and stress urinary incontinence.
This led a multitude of lawsuits being filed against the makers of these devices. American Medical Systems, C.R. Bard, Boston Scientific, and Johnson & Johnson’s Ethicon unit all have been named in various mesh implant lawsuits. The evidence in these cases demonstrates that these companies put their own corporate profits ahead of any concerns for patient safety.
We urge women who are having complications with any of the transvaginal mesh products or bladder or pelvic slings to seek immediate consultation to determine if they have a potential claim and are eligible for compensation.
Houssiere, Durant & Houssiere, LLP is accepting cases on behalf of patients harmed by these dangerous and defective surgical mesh products. We are committed to helping women who have been injured by these defective products. Please call us for a free consultation.